choriogonadotropin alfa

choriogonadotropin alfa, human chorionic gonadotropin produced by recombinant technology, used to induce ovulation and pregnancy in certain infertile, anovulatory women and to increase the numbers of oocytes for patients attempting conception using assisted reproductive technologies, such as gamete intrafallopian transfer or in vitro fertilization. It is administered subcutaneously.